针对ATF4-DDIT4/TXNIP诱导的线粒体功能障碍和铁:ISRIB作为感染性心肌病的新疗法
Yiting Chen1,2, Xueping Feng2,3, Zeyu Li1
1Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China.
Journal of translational medicine
|August 20, 2025
概括
败血症诱导的心肌病 (SIC) 的进展是由DDIT4/TXNIP介导的铁,由ATF4调节. 通过向ATF4,抑制剂ISRIB有效治疗SIC,减少铁亡并改善心脏功能.
科学领域:
- 心血管生物学
- 疾病的分子机制
- 败血症病理学
背景情况:
- 败血症引起的心肌病 (SIC) 具有显著的临床挑战,尽管早期可逆性,但死亡率高.
- 导致SIC进展的精确生物机制在很大程度上是未知的,因此需要进一步的研究.
研究的目的:
- 了解导致败血症心肌病的分子机制.
- 确定SIC的新疗法目标和干预策略.
主要方法:
- 使用共免疫沉和体外/体外模型研究了DDIT4/TXNIP相互作用及其在SIC中的作用.
- 通过PCR芯片,西式斑点,免疫光和流细胞测量来确定SIC细胞死亡的机制.
- 在SIC小鼠模型中评估ISRIB,一种ATF4抑制剂的治疗潜力.
主要成果:
- 通过TXNIP途径促进炎症透和心脏功能障碍,DDIT4使SIC恶化.
- DDIT4/TXNIP轴驱动SIC通过ferroptosis的进展,ATF4被确定为一个关键的上游调节器.
- 在SIC中,ISRIB显著降低了炎症和铁,改善了小鼠的心脏功能和预后.
结论:
- 由ATF4调节的DDIT4/TXNIP介导的铁死途径通过增加炎症和损害心脏功能而加剧SIC.
- 用小分子抑制剂ISRIB向ATF4提供了一种有希望的治疗策略,以减轻SIC中的铁和保护心脏功能.
- 这项研究确定了一种新的治疗目标和干预措施,用于治疗败血症引起的心肌病.
相关概念视频
The Electron Transport Chain
17.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.3K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Cardiomyopathy IV: Restrictive Cardiomyopathy
28
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
28


